期刊文献+

心脏手术后急性心功能衰竭患者采用静脉注射左西孟旦治疗的疗效观察 被引量:7

下载PDF
导出
摘要 目的研究并探讨采用静脉注射左西孟旦治疗心脏手术后急性心功能衰竭患者的临床疗效。方法对我院2011年2月至2012年2月间确诊收治并采用左西孟旦进行治疗的20例心脏手术后急性心功能衰竭患者患者的临床诊治资料进行观察分析,观察所有患者治疗前、治疗后24h、72h以及1周时的平均动脉压、中心静脉压、心率以及左心室射血分数等相关指标的变化。结果 20例患者中共有13例患者存活出院,其余7例患者均在治疗期间死亡。采用左西孟旦治疗24h后患者的左心室射血分数即明显好转(P<0.05),平均动脉压、中心静脉压以及心率等指标均有了一定程度的好转,用药后72h及一周时各项临床指标均持续好转。治疗期间有2例患者出现短时间的血压下降,降低药物注入速度后得以解决,其余患者并未出现严重的不良反应。结论采用左西孟旦治疗心脏手术后急性心功能衰竭患者能够显著改善患者的心脏功能,减少其他药物的使用量,对于患者预后的影响仍需进一步研究。
出处 《中国医药指南》 2013年第35期178-179,共2页 Guide of China Medicine
  • 相关文献

参考文献6

二级参考文献63

  • 1Kivikko M, Antila S, Eha J, ctal. Pharmacokinctics of Ievosimcndan and its mctabolites during and after a 24-hour continuous infusion in patients with severe heart failure[ J]. Int J Clin Pharmacoi Ther,2002,40(10) :465-471.
  • 2Ghcorghiade M, Tecdink JR, Mebazaa A. Pharmacology of New Agents for Acute Heart Failure Syndromes [ J ]. Am J Cardiol,2005 ,96 :68-73.
  • 3Sonntag S, Sundburg S, Lehtonen LA, et al. The Calcium Sensitizer Levosimendan Improves the Function of Stunned Myocardium After Percutaneous Transluminal Coronary Angioplasty in Acute Myocardial Ischemia [ J ]. J Am Coll Cardiol, 2004,43(12) :2177-2182.
  • 4Michaels AD, McKeown B, Kostal M,ct al. Effects of intravenous levosimendan on human coronary vasomotor regulation, leftventricular wall stress, and myocardial oxygen uptake[ J]. Circulation ,2005,111 : 1504-1509.
  • 5Maytin M, Colucci WS. Cardioprotection: A new paradigm in the management of acute heart failure syndromes [J ]. Am J Cardiol,2005,96(Suppl) :26G-31G.
  • 6Adamopoulos, Parissis JT, Iliodromitis EK,et al. Effects of Levosimendan Versus Dobutamine on Inflammatory and Apoptotic Pathways in Acutely Decompensated Chronic Heart Failure [ J]. Am J Cardiol,2006,98( 1 ) :102-106.
  • 7Cleland JG, Nikitin N, McGowan J. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure[ J]. Expert Rev Cardiovasc Ther,2004,2( 1 ) :9-19.
  • 8McMurray J ,Pfeffer MA. New therapeutic options in congestive heart failure: Part H[J ]. Circulation, 2002, 105 ( 18 ) : 2223 -2228.
  • 9Nieminen MS, Akkila J,Hasenfuss G,et al. Hemodynamic and ncurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure[ J]. J Am Coll Cardiol,2000,36(6) :1903-1912.
  • 10Moiseyev VS,Poder P,Andrejevs N,et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infaretion:a randomized, place bocontrolled, double-blind study ( RUSS- LAN) [J]. Eur Heart J,2002,23(18) :1422-1432.

共引文献122

同被引文献57

  • 1Oner E, Erturk M, Birant A, et al. Assessment of sus- tained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure. Cardiol J, 2014 May 20. [ Epub ahead of print].
  • 2Harrison RW, Hasselblad V, Mehta RH, et al. Effect of levosimendan on survival and adverse events after cardi- ac surgery: a meta-analysis. J Cardiothorac Vasc Anesth, 2013, 27: 1224-1232.
  • 3Mayorchak Y, Rahnavardi M, Haghshenaskashani A, et al. Preoperative levosimendan infusion in cardiac surger- y patients with severe left ventricular dysfunction: a pre- liminary report. Heart, Lung and Circulation, 2011, 20 : 800.
  • 4Toiler W, Algotsson L, Guarracino F, et al. Periopera- tive use of levosimendan : best practice in operative set- tings. J Cardiothorac Vase Anesth, 2013, 27: 361- 366.
  • 5Erb J, Beutlhauser T, Feldheiser A, et al. Influence of levosimendan on organ dysfunction in patients with se- verely reduced left ventricular function undergoing cardi- ac surgery. J Int Med Res, 2014, 42: 750-764.
  • 6Levin R, Degrange M, Del Mazo C, et al. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol, 2012, 17: 125-130.
  • 7Baysal A, Yanartas M, Dogukan M, et al. Levosimen- dan improves renal outcome in cardiac surgery: a ran- domized trial. J Cardiothorac Vasc Anesth, 2014, 28: 586-594.
  • 8Niu ZZ, Wu SM, Sun WY, et al. Perioperative levosi- mendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis. J Cardiovasc Pharmacol, 2014, 63: 107-112.
  • 9Maharaj R, Metaxa V. Levosimendan and mortality after coronary revascularisation: a meta-analysis of random- ized controlled trials. Crit Care, 2011, 15: R140.
  • 10Momeni M, Rubay J, Matta A, et al. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial. J Cardiothorac Vasc Anesth, 2011, 25: 419-424.

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部